clinical trial · NCT07796191
Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult Subjects
Jiangsu vcare pharmaceutical technology co., LTD·phase1·not yet recruiting·n = 84
Healthy Adult ParticipantsVC005 and verapamilVC005 and probenecidVC005 and metformin
brief summary
This study includes three groups of Drug-Drug Interaction( DDI ) studies: 1. To evaluate the effect of verapamil on the pharmacokinetics of a single oral dose of VC005 in healthy subjects; 2. To evaluate the effect of probenecid on the pharmacokinetics of a single oral dose of VC005 in healthy subjects; 3. To evaluate the effect of VC005 on the pharmacokinetics of a single oral dose of metformin tablets in healthy subjects.
started
Sep 20, 2026
primary completion
Nov 30, 2026
completion
Nov 30, 2026
last updated
Sep 1, 2026
official title
A Clinical Trial of Drug-drug Interactions for VC005 Tablets in Healthy Adult Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol